| Business Type | Exporter, Supplier, Retailer |
| Packaging | Bottle Or Blister Pack |
| Color | White |
| Type | Capsules |
| Click to view more | |
Product Details
Tafinlar is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) called ‘BRAF V600’. It is used for the treatment of:
\\n
\\n
melanoma (a skin cancer) that has spread or cannot be removed surgically. Tafinlar is used on its own or in combination with another cancer medicine, trametinib;
\\n
advanced (stage III) melanoma after surgery for it. Tafinlar is used in combination with trametinib;
\\n
advanced non-small cell lung cancer. It is used in combination with trametinib.
\\n
Tafinlar contains the active substance dabrafenib.Tafinlar is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) called ‘BRAF V600’. It is used for the treatment of:
\\n
\\n
melanoma (a skin cancer) that has spread or cannot be removed surgically. Tafinlar is used on its own or in combination with another cancer medicine, trametinib;
\\n
advanced (stage III) melanoma after surgery for it. Tafinlar is used in combination with trametinib;
\\n
advanced non-small cell lung cancer. It is used in combination with trametinib.
\\n
Tafinlar contains the active substance dabrafenib.Tafinlar is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) called ‘BRAF V600’. It is used for the treatment of:
\\n
\\n
melanoma (a skin cancer) that has spread or cannot be removed surgically. Tafinlar is used on its own or in combination with another cancer medicine, trametinib;
\\n
advanced (stage III) melanoma after surgery for it. Tafinlar is used in combination with trametinib;
\\n
advanced non-small cell lung cancer. It is used in combination with trametinib.
\\n
Tafinlar contains the active substance dabrafenib.
